{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:49:32Z","timestamp":1792813772644,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114651","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:44:14Z","timestamp":1680803054000},"page":"114651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method"],"prefix":"10.1016","volume":"162","author":[{"given":"Yomogi","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-1535","authenticated-orcid":false,"given":"Mohamed","family":"Elbadawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryouichi","family":"Tsunedomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Azakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Uchide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-3623","authenticated-orcid":false,"given":"Rina","family":"Nabeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-8258","authenticated-orcid":false,"given":"Amira","family":"Abugomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-2127","authenticated-orcid":false,"given":"Tatsuya","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/pp-2016-0009","article-title":"Diverse properties of the mesothelial cells in health and disease","volume":"1","author":"Kawanishi","year":"2016","journal-title":"Pleura Perito"},{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jdb7020007","article-title":"Mesothelium and malignant mesothelioma","volume":"7","author":"Hiriart","year":"2019","journal-title":"J. Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bulcan.2017.11.007","article-title":"Molecular heterogeneity of malignant pleural mesotheliomas","volume":"105","author":"Tranchant","year":"2018","journal-title":"Bull. du Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2023.114651_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification","volume":"17","author":"Sauter","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41379-021-00895-7","article-title":"Pleural mesothelioma classification\u2014update and challenges","volume":"35","author":"Dacic","year":"2022","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.biopha.2023.114651_bib6","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1111\/cas.14118","article-title":"Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture","volume":"110","author":"Elbadawy","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2023.114651_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113597","article-title":"Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues","volume":"154","author":"Abugomaa","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114651_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113105","article-title":"Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method","volume":"151","author":"Elbadawy","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cells9010235","article-title":"Emerging roles of cancer stem cells in bladder cancer progression, tumorigenesis, and resistance to chemotherapy: a potential therapeutic target for bladder cancer","volume":"9","author":"Abugomaa","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib10","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/ani11102770","article-title":"Evaluation of the safety and feasibility of apheresis in dogs: for application in metastatic cancer research","volume":"11","author":"Yamamoto","year":"2021","journal-title":"Animals"},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/vco.12777","article-title":"Clinical presentation, treatment and outcome of canine malignant mesothelioma: a retrospective study of 34 cases","volume":"20","author":"Moberg","year":"2022","journal-title":"Vet. Comp. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114651_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jsap.12830","article-title":"Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease","volume":"59","author":"Milne","year":"2018","journal-title":"J. Small Anim. Pract."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1292\/jvms.64.269","article-title":"Juvenile malignant mesothelioma in a dog","volume":"64","author":"Kim","year":"2002","journal-title":"J. Vet. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2046-0481-60-1-30","article-title":"Pleural mesothelioma in a nine-month-old dog","volume":"60","author":"Vural","year":"2007","journal-title":"Ir. Vet. J."},{"key":"10.1016\/j.biopha.2023.114651_bib15","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1038\/srep06152","article-title":"Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma","volume":"4","author":"Hudson","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1939-1676.1991.tb00953.x","article-title":"Intracavitary cisplatin chemotherapy experience with six dogs","volume":"5","author":"Moore","year":"1991","journal-title":"J. Vet. Intern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-9966-27-6","article-title":"Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations","volume":"27","author":"Spugnini","year":"2008","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1292\/jvms.69.201","article-title":"Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog","volume":"69","author":"Seo","year":"2007","journal-title":"J. Vet. Med. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.114651_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071881","article-title":"Experimental model of human malignant mesothelioma in athymic mice","volume":"19","author":"Colin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/17460441.2021.1867530","article-title":"Mouse models for mesothelioma drug discovery and development","volume":"16","author":"Seastedt","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2023.114651_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/cdd.2015.165","article-title":"Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease","volume":"23","author":"Chernova","year":"2016","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/php.13067","article-title":"Modeling epidermal growth factor inhibitor-mediated enhancement of photodynamic therapy efficacy using 3D mesothelioma cell culture","volume":"95","author":"Cramer","year":"2019","journal-title":"Photochem. Photobiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1165\/rcmb.2004-0355OC","article-title":"A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance","volume":"33","author":"Kim","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014640","article-title":"The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy","volume":"6","author":"Xiang","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150044","article-title":"Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma","volume":"11","author":"Barbone","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib26","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","article-title":"In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening","volume":"8","author":"Mazzocchi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114651_bib27","doi-asserted-by":"crossref","unstructured":"Y. Gao, M. Kruithof-de Julio, R.-W. Peng, P. Dorn, Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?, Cancers, 2022.","DOI":"10.3390\/cancers14153758"},{"key":"10.1016\/j.biopha.2023.114651_bib28","article-title":"Case report: microfragmented adipose tissue drug delivery in canine mesothelioma: a case report on safety, feasibility, and clinical findings","volume":"7","author":"Zeira","year":"2020","journal-title":"Front. Vet. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2023.114651_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1748-5827.1999.tb03105.x","article-title":"Pericardial mesothelioma in a dog: long-term survival after pericardiectomy in combination with chemotherapy","volume":"40","author":"Closa","year":"1999","journal-title":"J. Small Anim. Pract."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib30","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/v6062340","article-title":"Viral oncolysis - can insights from measles be transferred to canine distemper virus?","volume":"6","author":"Lapp","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.114651_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2020.01.030","article-title":"Organoid models in lung regeneration and cancer","volume":"475","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23808993.2020.1715794","article-title":"Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?","volume":"5","author":"Abugomaa","year":"2020","journal-title":"Expert Rev. Precision Med. Drug Dev."},{"key":"10.1016\/j.biopha.2023.114651_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119823","article-title":"Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model","volume":"237","author":"Elbadawy","year":"2020","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.biopha.2023.114651_bib34","doi-asserted-by":"crossref","first-page":"10763","DOI":"10.3390\/ijms221910763","article-title":"Establishment of intestinal organoid from rousettus leschenaultii and the susceptibility to bat-associated viruses, SARS-CoV-2 and Pteropine Orthoreovirus","volume":"22","author":"Elbadawy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1293\/tox.2022-0017","article-title":"The potential of organoids in toxicologic pathology: role of toxicologic pathologists in in vitro chemical hepatotoxicity assessment","volume":"35","author":"Yoshida","year":"2022","journal-title":"J. Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cancers12040777","article-title":"Development of prostate cancer organoid culture models in basic medicine and translational research","volume":"12","author":"Elbadawy","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/cancers10060164","article-title":"Development of an experimental model for analyzing drug resistance in colorectal cancer","volume":"10","author":"Elbadawy","year":"2018","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/ijms19041098","article-title":"Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture","volume":"19","author":"Usui","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib39","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1038\/s41598-020-66229-w","article-title":"Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture","volume":"10","author":"Abugomaa","year":"2020","journal-title":"Sci. Rep."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2023.114651_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/15384047.2021.1919004","article-title":"Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism","volume":"22","author":"Elbadawy","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2023.114651_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112043","article-title":"Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids","volume":"142","author":"Elbadawy","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biopha.2023.114651_bib42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10815-014-0277-1","article-title":"In vitro culture and characterization of spermatogonial stem cells on Sertoli cell feeder layer in goat (Capra hircus)","volume":"31","author":"Pramod","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.biopha.2023.114651_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-3-34","article-title":"Malignant mesothelioma","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058132","article-title":"Phenotypes and karyotypes of human malignant mesothelioma cell lines","volume":"8","author":"Relan","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/cas.13527","article-title":"Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells","volume":"109","author":"Nishiyama","year":"2018","journal-title":"Cancer Sci."},{"issue":"43","key":"10.1016\/j.biopha.2023.114651_bib47","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2023.114651_bib48","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/cas.14523","article-title":"Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma","volume":"111","author":"Horio","year":"2020","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.114651_bib49","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/cas.13418","article-title":"Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells","volume":"108","author":"Usui","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2023.114651_bib50","doi-asserted-by":"crossref","first-page":"7053872","DOI":"10.1155\/2016\/7053872","article-title":"Establishment of a novel model for anticancer drug resistance in three-dimensional primary culture of tumor microenvironment","volume":"2016","author":"Usui","year":"2016","journal-title":"Stem Cells Int."},{"issue":"9","key":"10.1016\/j.biopha.2023.114651_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2023.114651_bib52","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1016\/S2589-7500(21)00104-7","article-title":"The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study","volume":"3","author":"Zauderer","year":"2021","journal-title":"Lancet Digit. Health"},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib53","first-page":"301","article-title":"Sclerosing peritoneal mesothelioma in a dog: histopathological, histochemical and immunohistochemical investigations","volume":"50","author":"D'Angelo","year":"2014","journal-title":"Vet. Ital."},{"issue":"7","key":"10.1016\/j.biopha.2023.114651_bib54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1292\/jvms.18-0186","article-title":"Sarcomatoid mesothelioma of tunica vaginalis testis in the right scrotum of a dog","volume":"80","author":"Son","year":"2018","journal-title":"J. Vet. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib56","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejcts.2009.08.027","article-title":"Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma","volume":"37","author":"Schramm","year":"2010","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"issue":"20","key":"10.1016\/j.biopha.2023.114651_bib57","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1158\/0008-5472.CAN-20-1418","article-title":"ALPPL2 is a highly specific and targetable tumor cell surface antigen","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910470219","article-title":"Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions","volume":"47","author":"Manning","year":"1991","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2023.114651_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00418-004-0701-1","article-title":"Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis","volume":"122","author":"Philippeaux","year":"2004","journal-title":"Histochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.114651_bib61","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/thoraxjnl-2020-216602","article-title":"Use of preclinical models for malignant pleural mesothelioma","volume":"76","author":"Shamseddin","year":"2021","journal-title":"Thorax"},{"issue":"21","key":"10.1016\/j.biopha.2023.114651_bib62","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.cub.2017.09.007","article-title":"Long-fiber carbon nanotubes replicate asbestos-induced mesothelioma with disruption of the tumor suppressor gene Cdkn2a (Ink4a\/Arf)","volume":"27","author":"Chernova","year":"2017","journal-title":"Curr. Biol.: CB"},{"issue":"7","key":"10.1016\/j.biopha.2023.114651_bib63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/cas.12954","article-title":"Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors","volume":"107","author":"Suzui","year":"2016","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A conditional mouse model for malignant mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.biopha.2023.114651_bib65","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1158\/0008-5472.CAN-18-4093","article-title":"Inactivation of Bap1 cooperates with losses of Nf2 and Cdkn2a to drive the development of pleural malignant mesothelioma in conditional mouse models","volume":"79","author":"Kukuyan","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib66","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191257","article-title":"Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice","volume":"217","author":"Badhai","year":"2020","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.biopha.2023.114651_bib67","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1002\/jcp.26830","article-title":"Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas","volume":"233","author":"Sementino","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib68","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","article-title":"Patient-Derived Xenograft establishment from human malignant pleural mesothelioma","volume":"23","author":"Wu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2023.114651_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12885-015-1362-2","article-title":"Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma","volume":"15","author":"Kalra","year":"2015","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.biopha.2023.114651_bib70","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.biopha.2023.114651_bib71","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2023.114651_bib72","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.114651_bib73","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039556","article-title":"Changes in global gene expression associated with 3D structure of tumors: an ex vivo matrix-free mesothelioma spheroid model","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2013.03.005","article-title":"A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies","volume":"88","author":"Ranieri","year":"2013","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/joc.joc_145_21","article-title":"Cytological diagnosis of malignant mesothelioma: a case series","volume":"39","author":"Dahiya","year":"2022","journal-title":"J. Cytol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114651_bib77","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3892\/br.2014.306","article-title":"Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2","volume":"2","author":"Tsugeno","year":"2014","journal-title":"Biomed. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib78","first-page":"207","article-title":"EGFR overexpression in malignant pleural mesothelioma","volume":"51","author":"Destro","year":"2006","journal-title":"Immunohistochem. Mol. Study Clin. - Pathol. Correl., Lung Cancer (Amst., Neth.)"},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib79","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-008-0384-4","article-title":"Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma","volume":"134","author":"Okuda","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jso.21901","article-title":"Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations","volume":"104","author":"Rena","year":"2011","journal-title":"J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib81","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/JTO.0b013e3181ec18db","article-title":"A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307","volume":"5","author":"Dubey","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib82","article-title":"Targeting and efficacy of Novel mAb806-antibody-drug conjugates in malignant mesothelioma","volume":"13","author":"Chia","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"26","key":"10.1016\/j.biopha.2023.114651_bib83","doi-asserted-by":"crossref","first-page":"39861","DOI":"10.18632\/oncotarget.9515","article-title":"Inhibition of FGF\/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039\/GSK3052230","volume":"7","author":"Blackwell","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.biopha.2023.114651_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091091","article-title":"Expression of FGFR1-4 in malignant pleural mesothelioma tissue and corresponding cell lines and its relationship to patient survival and FGFR inhibitor sensitivity","volume":"8","author":"Vlacic","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib85","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1541-7786.MCR-14-0038","article-title":"Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma","volume":"12","author":"Marek","year":"2014","journal-title":"Mol. Cancer Res.: MCR"},{"issue":"1","key":"10.1016\/j.biopha.2023.114651_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1878-0261.12150","article-title":"A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma","volume":"12","author":"Schelch","year":"2018","journal-title":"Mol. Oncol."},{"issue":"36","key":"10.1016\/j.biopha.2023.114651_bib87","doi-asserted-by":"crossref","first-page":"49447","DOI":"10.1007\/s11356-021-15759-5","article-title":"Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives","volume":"28","author":"Elfadadny","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.114651_bib88","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/ijms20092340","article-title":"Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer","volume":"20","author":"Elbadawy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib89","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.3390\/ijms19103031","article-title":"Novel functions of death-associated protein kinases through mitogen-activated protein kinase-related signals","volume":"19","author":"Elbadawy","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2023.114651_bib90","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1074\/jbc.M709698200","article-title":"Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids","volume":"283","author":"Barbone","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2023.114651_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.58","article-title":"The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance","volume":"2","author":"Barbone","year":"2011","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.biopha.2023.114651_bib92","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3109\/07357900902769749","article-title":"Cell adhesion molecules: role and clinical significance in cancer","volume":"27","author":"Makrilia","year":"2009","journal-title":"Cancer Investig."},{"issue":"8","key":"10.1016\/j.biopha.2023.114651_bib93","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/cdd.2009.32","article-title":"Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates","volume":"16","author":"Daubriac","year":"2009","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.biopha.2023.114651_bib94","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevOncog.v13.i3.10","article-title":"Biological characteristics of cancers involving the serosal cavities","volume":"13","author":"Davidson","year":"2007","journal-title":"Crit. Rev. Oncog."},{"issue":"2","key":"10.1016\/j.biopha.2023.114651_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020174","article-title":"Ectopic expression of Ankrd2 affects proliferation, motility and clonogenic potential of human osteosarcoma cells","volume":"13","author":"Piazzi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2023.114651_bib96","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/labinvest.2008.15","article-title":"Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium","volume":"88","author":"Ito","year":"2008","journal-title":"Lab. Investig."},{"issue":"12","key":"10.1016\/j.biopha.2023.114651_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122825","article-title":"Serum and pleural soluble cell adhesion molecules in mesothelioma patients: a retrospective cohort study","volume":"14","author":"Tsagkouli","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.biopha.2023.114651_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910225","article-title":"The role of E-Cadherin and microRNA on FAK inhibitor response in malignant pleural mesothelioma (MPM)","volume":"22","author":"Yuen","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223004390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:24:41Z","timestamp":1778246681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223004390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":98,"alternative-id":["S0753332223004390"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114651","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114651"}}